Website profile

Pr Newswire

PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.

  • 6,002articles · 30d
  • 1+ day agolatest article
  • Aug 14, 2026earliest in window
  • 92%with images
  • 272avg words
articles per day
Categories
  • Economy, Business & Finance 2,820
  • Finance & Business 2,249
  • News 1,510
  • Business & Industrial 789
  • Science & Technology 654
  • Health & Wellness 609
  • Medical 563
  • Arts, Culture, Entertainment & Media 529

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
prnewswire.com > news-releases > ultima-genomics-to-advance-pangenome-aware-whole-genome-sequencing-analysis-at-population-scale-in-collaboration-with-nvidia-using-googles-deepvariant-302873179.html

Ultima Genomics to Advance Pangenome-Aware Whole Genome Sequencing Analysis at Population Scale in Collaboration with NVIDIA, using Google's DeepVariant

3+ day, 16+ hour ago   (458+ words) PR Newswire FREMONT, Calif., Sept. 9, 2026 /PRNewswire/ -- Ultima Genomics, a leader in ultra-high-throughput DNA sequencing, today announced a collaboration with NVIDIA to enable pangenome-aware whole genome sequencing (WGS) analysis at unprecedented scale. With the rapidly accelerating adoption of whole genome sequencing…...

@PRNewswire
prnewswire.com > news-releases > armata-pharmaceuticals-announces-new-publication-that-advances-understanding-of-phage-biology-to-support-development-of-next-generation-antibacterials-302868362.html

Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials

1+ week, 2+ day ago   (706+ words) PR Newswire LOS ANGELES, Sept. 3, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today…...

@PRNewswire
prnewswire.com > news-releases > tiny-blue-dot-foundation-opens-fifth-round-seeking-to-fund-rigorous-empirical-statistically-valid-and-sound-research-on-the-neural-experiential-and-psychological-factors-related-to-the-perception-box-302866703.html

Tiny Blue Dot Foundation Opens Fifth Round Seeking To Fund Rigorous, Empirical, Statistically Valid, And Sound Research on the Neural, Experiential, and Psychological Factors Related To The Perception Box

1+ week, 4+ day ago   (211+ words) Sep 01, 2026, 14:41 ET Understanding what shapes our Perception Box may reveal new possibilities for how we experience ourselves and the world. The new RFP follows the Foundation's recent announcement of $9 million in funding for 11 new research projects, bringing the total number…...